What it sells
FidoCure® is the leader in Precision Medicine for Canine Oncology.
Business model breakdown
Buyer: who owns the budget?
UnverifiedVeterinarian, with cost passed to pet owner.
Workflow: what inputs become what output?
Vet submits tumor sample, FidoCure sequences it to find mutations and recommends targeted therapies; vet orders drugs from compounding pharmacies (FidoCure does not prescribe).
Distribution: how it reaches customers
Sold through veterinarians via portal; webinars, case studies and blog.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2018 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.